Antisense compounds, compositions and methods are provided for modulating
the expression of C-reactive protein. The compositions comprise antisense compounds,
particularly antisense oligonucleotides, targeted to nucleic acids encoding C-reactive
protein. Methods of using these compounds for modulation of C-reactive protein
expression and for treatment of diseases associated with expression of C-reactive
protein are provided.